Medicare drug plans can now cover Eli Lilly’s blockbuster obesity drug Zepbound for obstructive sleep apnea, the Centers for Medicare & Medicaid Services confirmed to CNBC.
That opens the door for broader coverage of and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss specifically.
